Red Door Wealth Management »

Heron Therapeutics shares owned by Red Door Wealth Management

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by Red Door Wealth Management from 13F filings

Historical chart of Red Door Wealth Management investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by Red Door Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by Red Door Wealth Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $14k 10k 1.30

More positions owned by Red Door Wealth Management

Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl C (GOOG)
2023 Etf Series Trust Eagle Capital Se (EAGL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Wal-Mart Stores (WMT)
Meta Platforms Cl A (META)
Visa Com Cl A (V)
Ishares Tr Core S&p500 Etf (IVV)
Costco Wholesale Corporation (COST)

View all positions for Red Door Wealth Management

Top funds holding Heron Therapeutics

Rubric Capital Management
Clearline Capital
Adage Capital Partners GP
BlackRock
Vanguard Group
Velan Capital Investment Management
Palisade Capital Management
Tang Capital Management
Tejara Capital
Baker Bros. Advisors
Geode Capital Management
State Street Corporation
JW Asset Management
D. E. Shaw & Co
Congress Park Capital

View all funds holding Heron Therapeutics